Targeting vasoactive intestinal peptide-mediated signaling enhances response to immune checkpoint therapy in pancreatic ductal adenocarcinomaSruthi Ravindranathan(Emory University), Edmund K. Waller(Emory University)Nature CommunicationsOctober 27, 202210.1038/s41467-022-34242-4Cited by 34SaveCiteExport RISWatch citationsRelated PapersActivation of VIP signaling enhances immunosuppressive effect of MDSCs on CMV-induced adaptive immunity|Oncotarget|2017|10